Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024
Compare Balance Sheet Results of Shelter Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
11.56
20.00
-8.44
-42.20%
Share Warrants & Outstandings
Total Reserve
31.16
2.22
28.94
1,303.60%
Shareholder's Funds
42.72
22.22
20.50
92.26%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.93
4.20
-3.27
-77.86%
Secured Loans
0.00
4.20
-4.20
-100.00%
Unsecured Loans
0.93
0.00
0.93
0.00%
Deferred Tax Assets / Liabilities
-0.03
0.87
-0.90
-103.45%
Other Long Term Liabilities
0.05
2.73
-2.68
-98.17%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.19
-0.19
-100.00%
Total Non-Current Liabilities
0.95
7.99
-7.04
-88.11%
Current Liabilities
Trade Payables
1.25
2.62
-1.37
-52.29%
Other Current Liabilities
3.27
0.08
3.19
3,987.50%
Short Term Borrowings
0.11
0.71
-0.60
-84.51%
Short Term Provisions
0.00
0.15
-0.15
-100.00%
Total Current Liabilities
4.63
3.56
1.07
30.06%
Total Liabilities
48.30
33.77
14.53
43.03%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
8.36
24.84
-16.48
-66.34%
Less: Accumulated Depreciation
2.39
4.97
-2.58
-51.91%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.96
19.87
-13.91
-70.01%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.68
0.00
0.68
0.00%
Long Term Loans & Advances
8.39
2.26
6.13
271.24%
Other Non Current Assets
0.00
0.76
-0.76
-100.00%
Total Non-Current Assets
15.03
22.89
-7.86
-34.34%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
12.90
2.44
10.46
428.69%
Sundry Debtors
9.47
3.21
6.26
195.02%
Cash and Bank
3.42
1.16
2.26
194.83%
Other Current Assets
1.77
0.00
1.77
0.00%
Short Term Loans and Advances
5.72
4.07
1.65
40.54%
Total Current Assets
33.28
10.88
22.40
205.88%
Net Current Assets (Including Current Investments)
28.65
7.32
21.33
291.39%
Total Current Assets Excluding Current Investments
33.28
10.88
22.40
205.88%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
48.30
33.77
14.53
43.03%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
1.04
4.91
-3.87
-78.82%
Book Value per share (adjusted)
36.14
11.11
25.03
225.29%
Annual - Borrowings
Borrowings 1.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.05 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Annual - Investments
Investments 0.68 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 33.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024
